Press

Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5

Jul 29 • 2 min read

Quick Take: Cybin has recieved approval for its common shares to be listed on the NYSE around August 5th. Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has received approval for the listing of its common shares on the NYSE American LLC stock exchange (“NYSE American”). The Company…

Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP

Jul 27 • 2 min read

Quick Take: Field Trip Health will begin trading on the NASDAQ beginning July 29. Field Trip Health Ltd. (TSX: FTRP) , a global leader in the development and delivery of psychedelic therapies, announced today that it has received final approval from The NASDAQ Stock Market LLC (“NASDAQ”) to list its common shares on the NASDAQ…

Awakn Life Sciences Commences Trading on the OTC Market on July 26, 2021 Under the Symbol ‘AWKNF’

Jul 26 • 2 min read

Quick Take: Awakn Life Sciences has received approval from the Financial Regulatory Authority to commence trading on the OTC market. Awakn Life Sciences Corp. (NEO: AWKN) (OTC Pink: AWKNF), a biotechnology company with clinical operations developing and delivering psychedelic medicines to better treat addiction, today announced approval from the Financial Regulatory Authority (“FINRA”) for its…

Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol “FTRP”

Jul 23 • 3 min read

Quick Take: Field Trip Health has received conditional approval to trade its common stock on the NASDAQ. Field Trip Health Ltd. (TSX: FTRP, OTCQX: FTRPF), a global leader in the development and delivery of psychedelic therapies, announced today that it has received conditional approval from The NASDAQ Stock Market LLC (“NASDAQ”) to list its issued…

Cybin Announces Conditional Listing Approval from NYSE American

Jul 22 • 1 min read

Quick Take: Cybin has received conditional listing approval from the New York Stock Exchange Cybin Inc. (NEO:CYBN), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has received conditional listing approval from the NYSE American LLC stock exchange (the “NYSE American”). “Conditional listing approval on the NYSE American is an important milestone in…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435